Catherine E. Owen is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,976 shares of AGIO, which is worth approximately $93,721. The most recent transaction as insider was on Jun 13, 2024, when has been sold 1,976 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.98K
n/a 3M change
n/a 12M change
Total Value Held $93,721

Catherine E. Owen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
BUY
Exercise of conversion of derivative security
-
1,976 Added 50.0%
1,976 Common Stock

Also insider at

OPTN
OptiNose, Inc. Healthcare
CEO

Catherine E. Owen

Director
Yardley, PA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO